Search results
Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
Insider Monkey via Yahoo Finance· 2 days agoIn this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 3 days agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Bayer: The pharmaceutical company behind Leverkusen's success - and its difficult past
New York Times· 3 days agoUnder head coach Xabi Alonso, Bayer Leverkusen have won the Bundesliga and are on the cusp of...
Could the internet be ... good for you? Here's what to know about this week's health headlines
Yahoo Life Style via AOL· 6 days ago...this increase will be due to public health measures that reduce deaths from various communicable...
How biologics can help with symptoms of Crohn's
Medical News Today· 7 days agoBiologic therapies for Crohn’s disease (CD) do more than reduce the common symptoms of diarrhea, abdominal cramping, and pain. CD and ulcerative colitis...
Molecular Identification of Fonsecaea monophora, Novel Agent of Fungal Brain Abscess
Centers for Disease Control and Prevention· 20 hours agoA 3-year-old boy was admitted to the All India Institute of Medical Sciences, New Delhi, India, with headache for 3 weeks and 2 episodes of seizures. Fundoscopic examination revealed bilateral ...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
Evotec (EVO) to Release Earnings on Wednesday
ETF DAILY NEWS· 4 days agoEvotec (NASDAQ:EVO – Get Free Report) is set to release its earnings data before the market opens on Wednesday, May 22nd. Analysts expect Evotec to post earnings of ($0.07) per share for the ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced the availability of SIMLANDI (adalimumab-ryvk ...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days agoTeva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO),today announced the availability of SIMLANDI (adalimumab-ryvk) ...
